Protection by the administration of recombinant IL-22 has been repeatedly verified in models of acute liver injury (ALI) induced by concanavalin A (ConA) [15], lipopolysaccharide/d-galactosamine [18], alcohol [19], or acetaminophen (APAP) [20,21,22]. This evidence concerns the gene IL22 and acute respiratory distress syndrome.